Other hedge funds and other institutional investors have also added to or reduced their stakes in the company. Jennison Associates LLC raised its position in Axon Enterprise by 23,203.7% in the first quarter. Jennison Associates LLC now owns 614,053 shares of the biotechnology company's stock worth $322,961,000 after acquiring an additional 611,418 shares during the period. Nuveen LLC bought a new stake in Axon Enterprise in the first quarter worth about $264,796,000. Westfield Capital Management Co. LP raised its position in Axon Enterprise by 29.8% in the first quarter. Westfield Capital Management Co. LP now owns 927,801 shares of the biotechnology company's stock worth $487,977,000 after acquiring an additional 212,931 shares during the period. Vanguard Group Inc. raised its position in Axon Enterprise by 2.2% in the first quarter. Vanguard Group Inc. now owns 8,632,008 shares of the biotechnology company's stock worth $4,540,005,000 after acquiring an additional 185,571 shares during the period.